← Back to headlines
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out - Reuters
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out Reuters
23 Feb, 11:43 — 23 Feb, 11:43
Sources
Showing 1 of 1 sources
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out Reuters